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Abstract
Apoptosis is a highly conserved biochemical mechanism which is tightly controlled in cells.
It contributes to maintenance of tissue homeostasis and normally eliminates highly prolifer-
ative cells with malignant properties. Induced pluripotent stem cells (iPSCs) have recently
been described with significant functional and morphological similarities to embryonic stem
cells. Human iPSCs are of great hope for regenerative medicine due to their broad potential
to differentiate into specialized cell types in culture. They may be useful for exploring dis-
ease mechanisms and may provide the basis for future cell-based replacement therapies.
However, there is only poor insight into iPSCs cell signaling as the regulation of apoptosis.
In this study, we focused our attention on the apoptotic response of Alzheimer fibroblast-
derived iPSCs and two other Alzheimer free iPSCs to five biologically relevant kinase inhibi-
tors as well as to the death ligand TRAIL. To our knowledge, we are the first to report that
the relatively high basal apoptotic rate of iPSCs is strongly suppressed by the pancaspase
inhibitor QVD-Oph, thus underlining the dependency on proapoptotic caspase cascades.
Furthermore, wortmannin, an inhibitor of phosphoinositid-3 kinase / Akt signaling (PI3K-
AKT), dramatically and rapidly induced apoptosis in iPSCs. In contrast, parental fibroblasts
as well as iPSC-derived neuronal cells were not responsive. The resulting condensation
and fragmentation of DNA and decrease of the membrane potential are typical features of
apoptosis. Comparable effects were observed with an AKT inhibitor (MK-2206). Wortman-
nin resulted in disappearance of phosphorylated AKT and activation of the main effector
caspase-3 in iPSCs. These results clearly demonstrate for the first time that PI3K-AKT rep-
resents a highly essential survival signaling pathway in iPSCs. The findings provide
improved understanding on the underlying mechanisms of apoptosis regulation in iPSCs.
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Introduction
Since the discovery by Yamanaka and co-workers [1] in the year 2006, induced pluripotent
stem cells (iPSCs) are considered similar to embryonic stem cells (ESCs) with respect to pluri-
potency and quality. iPSCs are a promising ESCs alternative with similar differentiation poten-
tial, especially as a model to elucidate intractable disease mechanisms using original human
cells of a patient [2–5]. These cells can differentiate into the three fundamental germ layers and
thus give the researcher a great opportunity to develop over 200 human cell types in a dish for
studying cellular processes, development of a tissue as well as underlying disease mechanisms,
especially e.g. neurodegenerative or monogenic disorders [2,4,6,7]. Moreover, they could be
used to replace disease-damaged cells and to investigate toxicological effects of drugs [8].
Unlike ESCs, development of iPSCs does not require any damage of embryos, but uses e.g. easy
accessible skin cells like fibroblast cells. Another important advantage is that they can be gener-
ated directly from the patient's own cells, thereby circumventing the risk of rejection in case of
cell replacement in patients and creating an effective treatment of each individual [9]. How-
ever, it is noteworthy that the undifferentiated iPSCs like ESCs have the propensity to develop
into non-invasive tumours after transplantation in mice due to their unlimited proliferative
potential [10]. These tumours exhibit histologically disordered structures of all three germ lay-
ers. Recently it has been reported that ESCs can be transformed after a long period in culture
and are able to form aggressive tumors, so called teratocarcinomas [11,12]. As iPSCs behave
similar to ESCs, it should be assumed that they possess the same propensity. Therefore, eluci-
dating the poorly studied cell survival signalling pathways and death signalling pathways (e.g.
apoptosis) in iPSCs is an urgent need which will provide new insight in their biological behav-
iour and allows us to generate an optimal autologous stem cell-replacement therapy without
tumour formation.
Apoptosis failure due to multiple mutations promotes tumour development, whereas an
uncontrolled excess of apoptosis is responsible for the development of neurodegenerative dis-
eases such as Alzheimer's [13–15]. Proapoptotic signalling pathways possess far-reaching con-
sequences for the fate of individual cells and are counter-regulated at multiple levels. The
affected tissue is therefore well protected. Apoptosis can be triggered by the occurrence of proa-
poptotic and loss of antiapoptotic signals. Biological homeostasis and physiological functions
in the tissue are based on the balance of these two regulatory limbs. The proteins of the Bcl-2
(B cell lymphoma oncogene 2) family are important decisive regulators of apoptosis [15,16].
For many cellular systems, it is assumed that the molar ratio between proapoptotic (BAX,
BAK, BCL-XS, BAD, PUMA, and others) and anti apoptotic (BCL-2, Bcl-XL, MCL-1, A1, etc.)
members of the Bcl-2 family can decide on the susceptibility to apoptotic signals [17]. In addi-
tion to these, caspases, a family of cysteinyl aspartate-specific proteases, are central mediators
of apoptotic and inflammatory processes. They conduct death signals and are capable to cleave
a number of proteins known as death substrates to enhance the apoptotic signals and to com-
plete the apoptotic process [18]. Surprisingly both, the apoptotic initiator caspase-8 and the
effector caspase-3 are essential for iPSC reprogramming [19].
The cell survival signaling PI3K (phosphoinositide 3-kinase) pathway plays a crucial role
for mitogenesis, proliferation, prevention of apoptosis, maintenance of multipotency in mesen-
chymal stem cells (MSCs) and pluripotency in ESCs [20,21]. It can be activated exogenously by
growth factors and cytokines and endogenously by the constitutively active Ras protein. Both
apoptosis and survival of cells can be controlled by proteins such as AKT/PKB (protein kinase
B) involved in the PI3K pathway [21]. Phosphorylated AKT enhances survival and inhibits
apoptosis by phosphorylation and inactivation of several target proteins including the proa-
poptotic BAD and the tumour suppressor p53, a regulator of bcl-2 and bax genes [22,23].
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Moreover, several studies have recently reported that the AKT/PKB signaling pathway is
involved in cell survival in various cancers such as colon carcinoma, glioma, melanoma, breast
and liver carcinoma due to the abnormal activation of the downstream gene AKT [24–26]. Sev-
eral sudies demonstrated that the PI3K signalling pathway is essential and crucial for prolifera-
tion, survival and maintance of pluripotency in mouse embryonic stem cells [21].
To date the role of the PI3K-AKT signalling pathway and its cellular response in human
iPSCs have been poorly defined. Known is, however, that PI3K-AKT signalling is involved in
early steps of the reprogramming process in order to switch from oxidative phosphorylation
to glycolysis [27,28]. PI3K signalling parallel to upregulation of glycolytic gene expression
during reprogramming processes shows in particular that AKT activates two key glycolytic
regulators, AS1060 and PFKB2 [29]. Another study reported that PS48, an activator of
PI3K-AKT, is able to enhance reprogramming by upregulating glycolytic genes [30]. Also in
this context, Chen et al., [31] demonstrated an enhancement of somatic reprogramming in
mice by application of LY294002, another PI3K inhibitor. Therefore, understanding of
PI3K-AKT signalling in iPS cells, especially regarding their similarity to cancer cells, is of
great importance.
In this study we used the small molecule PI3K inhibitor wortmannin and the AKT in-
hibitor MK-2206 to investigate the molecular consequences of this prominent target signal-
ling pathway in three different iPSC lines which were derived from skin fibroblasts of an
Alzheimer patient, from normal human fibroblasts and from human foreskin fibroblasts,
respectively. The three iPS cell lines used in this study were generated by three different
reprogramming approaches. Additionally, we controlled four other relevant pathways using
three small molecule inhibitors and one apoptosis inducer. All of these pathways are dysre-
gulated in cancer due to mutations of the genes involved. The Pan-RAF inhibitor L-779,450
which suppresses cell proliferation in melanoma cell lines both with mutated B-Raf and
with wild-type B-Raf [32], BMS-345541, an IKK-2 inhibitor that addresses the NF-kappaB
pathway and has antiinflammatory properties and Aurora kinase an inhibitor MLN-8237
(AKA-I), which inhibits a member of the novel family of Aurora serine/threonine kinases
crucial for cell cycle control [33]. As apoptosis inducer we used Tumor Necrosis Factor
Related Apoptosis Inducing Ligand (TRAIL) which is important for the immune system.
TRAIL belongs to the TNF / TNFR (Tumor Necrosis Factor Receptor) superfamily. Its mis-
sion is to inactivate target cells by the extrinsic pathway of apoptosis, but most cancer cells
are resistant to this agent [34–36]. Furthermore we tested the p53 pathway using pifithrin-
alpha (PFT-alpha), a pharmacological inhibitor of p53 [37]. The aim of this study was to
determine whether there are differences regarding the apoptotic behaviour on the cellular
and molecular level between generated iPSCs, parental fibroblast cells and iPS derived neu-
rons after treatment with different inhibitors of crucial signalling pathways involved in can-
cer. Overall, striking differences could be shown in the reaction of the iPS cell lines to small
molecules versus the original skin fibroblasts they were derived from or versus terminally
differentiated neurons derived form these iPSCs.
Materials and Methods
Ethics statement
Full-thickness skin biopsy was resected from the forearm of a patient undergoing surgery. A
small skin biopsy (6 mm) of a not sun-exposed body region (inside upper arm) was removed.
The procedure was performed under local anesthesia. The study protocol has been approved
by the Charité Universitätsmedizin Berlin ethics committee. Ethical agreement was preliminar-
ily obtained from the guardian of the participant including written informed consent.
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Cell culture
For this study we used frozen iPSCs generated from skin cells taken from an Alzheimer patient
as described in a previous study [5]. Briefly, after two years of storage in liquid nitrogen the
iPSCs were quickly thawed at 37°C and cultured in hESCs medium containing KO-DMEM
supplemented with 20% knockoutTM serum replacement, 1% nonessential amino acids, 1% L-
glutamine, penicillin/streptomycin, 1% sodium pyruvate, 0.1 mM beta-mercaptoethanol (all
from Invitrogen, Karlsruhe, Germany) and 8 ng/ml basic fibroblast growth factor (bFGF) (Pre-
protech, Rocky Hill, NJ, USA) on dishes coated with matrigel (BD; San Diego, CA). Subse-
quently iPSCs were cocultured with mitomycin-c treated feeder cells (CF1 MEF, p3, Cell
System, Troisdorf, Germany) for 5 weeks. When showing their typical morphology, the iPSCs
were passaged manually and transferred into a new matrigel-coated feeder-free plate. The cells
were grown in 5% CO2 with 95% humidity in mTeSR1 medium complete kit (STEMCELL
Technologies SARL, Cologne, Germany). The medium was changed daily, iPSCs were passaged
every 6 days with 5 U/mL dispase (STEMCELL Technologies SARL) at 37°C for 7–10 min, and
spontaneously arising differentiated cells were removed manually under a microscope. In our
study, we used the following 5 small molecules, namely wortmannin (0.5–4μM, PI3K inhibitor,
Santa Cruz Biotechnologies, Santa Cruz, CA, USA), MK-2206 (2μM, AKT inhibitor, (8-,4-,1-
aminocyclobutyl)phenyl)-9-phenyl-(1,2,4)trizolo(3,4-f)(1,6naphthyridin-3(2H)-one; Sellek-
chem, Munich, Germany), L-779,450 (4μM, pan-RAF inhibitor, Merck, Darmstadt, Ger-
many;), BMS-345541 (4μM, IKK-2 inhibitor that addresses the NF-kappaB pathway; Sigma-
Aldrich, Taufkirchen, Germany), MLN-8237 (50nM, Aurora A-kinase inhibitor, Seleckchem,
Munich, Germany), and the death ligand TRAIL (10ng/ml, Alexis, Gruenberg, Germany). For
caspase inhibition, iPSCs were pretreated for 1h with 10 μM of the pancaspase inhibitor QVD-
oph (MP Biomedicals, Solon, OH, USA).
Furthermore we used two other iPSC lines. iPSC line BIHi001-A was derived from human
foreskin fibroblasts (HFF; CCD-1112Sk, American Type Culture Collection (ATCC) were
reprogrammed using Sendai virus vectors expressing Oct3/4, Sox2, Klf4, and c-Myc (Cyto-
Tune-iPSC reprogramming kit, Life Technologies)). The iPSC line BIHi004-A was derived
from normal human fibroblasts (NHDF-Ad-Der Fibroblasts, Lonza, Basel, Switzerland) using
episomal vectors expressing Oct3/4, Sox2, Klf4, L-Myc, Lin28 mp53DD, and EBNA1 (Epi5
Episomal iPSC Reprogramming Kit, Life Technologies). Both iPSC lines were cultivated in
Essential 8 Medium (E8, Thermo Fisher Scientific). Cells were tested for absence of remaining
reprogramming vectors, expression of the pluripotency markers OCT4, SSEA4, TRA-1-60,
TRA-1-81, SOX2 and differentiation capacity into cells of the three germ layers. Detailed infor-
mation and characterization data of the lines is available in the hPSCreg database (http://
hpscreg.eu/cell-line/ BIHi001-A, http://hpscreg.eu/cell-line/ BIHi004-A). For p53 inhibition,
all three iPSCs were pretreated for 2h with 4μM, 10μM and 50μM PFT-alpha (Sellekchem).
Alkaline phosphatase analysis and immunofluorescence staining
Alkaline phosphatase (AP) activity was visualized by using the commercially available AP
staining kit (AP-red, Millipore, cat. no. SCR004, Schwalbach, Germany; AP-blue, Sigma
Aldrich, cat. no. AB0300), according to the manufacturer's instructions. In order to character-
ize AD-iPSC colonies in terms of pluripotency properties, the cells were stained employing
immunocytochemistry. Cells were first fixed in phosphate-buffered saline (PBS) containing 4%
paraformaldehyde (Science Services, Munich, Germany) for 20 min at room temperature, sub-
sequently washed twice with PBS without Ca2+ and Mg2+and finally blocked with 10% FBS
serum (Vector Laboratories, Loerrach, Germany) and 0.1% Triton X-100 (Sigma-Aldrich) in
PBS. A prominent stem cell marker was used as primary antibody, NANOG (1:100, Abcam,
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cat. no. ab62734, Cambridge, UK), followed by an Alexa-488-conjugated secondary antibody
(1:300, Invitrogen, cat. no. A11001). Nuclei were counter-stained with 40,6-Diamidin-2-pheny-
lindol (200 ng/ml, DAPI, Invitrogen) and visualized using fluorescence microscopy.
Quantitative real-time polymerase chain reaction and data analyses
Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Germantown, MD, USA,) accord-
ing to the manufacturer's instructions. In each case 1 μg RNA was used to generate cDNA
using SuperScriptIII First Strand Synthesis System for RT-PCR (Thermo Fisher Scientific, Wal-
tham, USA). Quantitative real-time PCR (RT-qPCR) was performed with SYBR1Green PCR
Master Mix (Applied Biosystems, Foster City, CA, USA) on a Quant Studio 6 Real-Time PCR
machine and analyzed using the QuantStudio™ Real-Time PCR Software (Applied Biosystems,
Foster City, CA, USA) and Microsoft Excel. Samples were normalized to HPRT (Hypoxanthine
Phosphoribosyltransferase) as housekeeping gene and analyzed using the deltadeltaCt method.
All primer sequences are provided in S1 Table. For detection of pluripotency-associated genes
in AD-iPS, BHIi001-A-iPS and BHIi004-A-iPS, the undifferentiated hESC line WAe001-A
(H1) (positive control) and Human Foreskin Fibroblasts (HFF, negative control) were used.
All qPCR data are presented as mean ± s.e.m. of at least three replicates.
Neuronal differentiation
Neuronal cells were generated according to a recently published protocol, [38]. Briefly, AD-
iPSCs were cultured in mTeSR1 medium (STEM CELL) on 6 well plates coated with Matrigel
(BD Bioscience) for two weeks. Induction of neuronal cells was performed by adding 10 μM
SB431542 (SB, TGF-beta receptor inhibitor) and 1 μM PD0325901 (PD, MEK1/2 inhibitor)
(both from Sigma-Aldrich) in the absence of bFGF (Preprotech; Rocky Hill, NJ) [38]. The cells
were grown for additional six weeks and the medium was changed daily. Furthermore, induced
neurons from BIHi001-A and BIHi004-A were generated by forced expression of the transcrip-
tion factor Ngn2 as previously described [39]. Briefly, iPSCs were transduced with lentiviral
vectors expressing Ngn2 and rtTA as well as a puromycin resistance gene. Ngn2 expression
was induced by the addition of doxycyclin (2 μg/μl) on day 0 and succesfully infected cells were
selected by addition of puromycin (1μg/ml) for 2 days. To avoid contamination of the follow-
ing assays with mouse astrocytes, induced neurons were cultured suspended above an astrocyte
feeder layer [40] The obtained neuronal cells were treated with wortmannin after eight weeks
(AD-iPSCs) or after 21 days (BIHi001-A and BIHi004-A) and used for Western blotting and
measurement of apoptosis by FACS analysis.
Apoptosis detection and cell cycle analysis
For quantification of apoptosis and cell cycle arrest, cell cycle analyses were performed [17]. In
brief, treated cells (usually 1 h to 24 h) were harvested using accutase (Millipore, Schwalbach,
Germany) and stained for 1 h with propidium iodide (200 mg/ml; Sigma-Aldrich). Sub-G1
fractions corresponding to cells with fragmented DNA were quantified by flow cytometry
(FACS Calibur, BD Bioscience, Bedford, MA, USA; 10,000 cells gated, FL3H, and MACSQuant
VYB, Miltenyi Biotec, Bergisch Gladbach, Germany; 10,000 cells counted). Apoptosis induc-
tion and cell cycle arrest of treated cells were compared to untreated controls. Apoptosis was
subsequently quantified by using a cell death detection enzyme-linked immunosorbent assay
(ELISA) (Roche Diagnostics, Mannheim, Germany), which detects mono- and oligonucleo-
somes formed in apoptotic cells according to a protocol described previously [41]. We diluted
the samples 1: 500 so that a slow colour reaction could take place, since the induction of apo-
ptosis with wortmannin is very strong. Relative apoptotic rates were calculated as the ratio of
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ELISA values of wortmannin treated cells to non-treated cells. Each assay consisted of triple
values, and at least three independent experiments were performed.
For visualization of typical features of apoptosis, we treated iPSCs with wortmannin for 1h
and fixed the cells in 4% paraformaldehyde (Science Services) for 20 min at 4°C in 24 well
plates and washed them once with PBS. 1 μg/ml Hoechst-33258 dye (Sigma-Aldrich) was
added for 20 min at room temperature after which cells were washed again with PBS. Cells
were examined by fluorescence microscopy. Apoptotic cells were identified by condensed and
fragmented nuclei. For further confirmation of apoptosis induction we used the cell death
detection kit.
Determination of mitochondrial membrane potential and reactive oxygen
species formation
Mitochondrial membrane potential was determined with the fluorescent dye TMRM+ (1 mM;
tetramethylrhodamine methyl ester perchlorate; Sigma-Aldrich). Cells were treated with wort-
mannin for 1–24 h, harvested by accutase and stained with TMRM+ for 15 min at 37°C. Then,
iPSCs were measured in PBS by flow cytometry in a FACS Calibur (1x 104 gated cells, FL2H).
For determination of intracellular reactive oxygen species (ROS), cells were treated for 0.5–
24h. After using accutase, cells were stained for 30min with the fluorescent dye 20,70-dichloro-
dihydrofluoresceindiacetate (15mM; H2DCFDA, Molecular Probes, Invitrogen, Eugene, OR,
USA) and measured in PBS by flow cytometry in a FACS Calibur (104 gated cells, FL1H). For
ROS scavenging, cells were pretreated for 1h with 200–400μM alpha-tocopherol (vitamin E)
(Fluka, Steinheim, Germany). As positive control, cells were treated with 200mMH2O2 for 1h.
Western Blot
Human iPSCs and their corresponding fibroblasts as well as iPSC-derived neurons were
detached from the surface of the cell culture dish by incubation with accutase. For protein
extraction, cells were harvested within 1–24 h after wortmannin treatment and lysed in RIPA
buffer supplemented with complete protease inhibitor and phosphatase inhibitor cocktail
(Roche, Penzberg, Germany). Extracts were homogenized and centrifuged at 12000×g for 10
min. SDS–polyacrylamide gel electrophoresis (PAGE) and Western blot analysis of total pro-
teins were performed as previously described [42]. The following antibodies were used: pri-
mary antibodies from Cell Signaling (Danvers, MA, USA), cleaved caspase-3 (3664, rabbit, 1:
1000), P-BAD (9292, rabbit, 1: 1000); primary antibodies from Santa Cruz Biotech, Bcl-2 (sc-
7832, rabbit; 1: 200), BAX (sc-493, rabbit, 1: 200), PUMA (sc-374223, rabbit, 1: 1000), p53 (sc-
6243, rabbit, 1:200) and from Novus light chain 3A (LC3A) (NB100-2331, rabbit, 1:50). As
loading control for the same amount of proteins primary antibodies for alpha-actin and beta-
tubulin from the Loading Control Antibody Sampler Kit from Cell Signaling (4670, rabbit,
1:500) were used. After incubation with a peroxidase-labelled anti-rabbit and anti mouse sec-
ondary antibody (1:5000, Dako, Hamburg, Germany), antigen–antibody complexes were
detected by ECLWestern blotting detection reagents (Peqlab, Erlangen, Germany). One to
15 min exposures were analysed with the Fusion FX7 imaging system (Peqlab).
Statistical analyses
Assays consisted of triplicates, and at least two independent experiments were performed.
Mean values and standard deviations (SD) were calculated by enclosing all individual values of
the independent experiments (at least 6 values). Statistical significance was proven by Student’s
t-test (normal distribution) and p-values of< 0.05 were considered statistically significant.
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Results
Cultivation of thawed iPSCs and their characterization in terms of
pluripotent properties
Human AD-iPSCs arised from skin fibroblasts through gene delivery using a retroviral vector
containing the four transcription factors OCT4, SOX2, KLF4 and C-MYC as reported in a pre-
vious study [5]. One iPSC clone was thawed quickly after two years liquid nitrogen storage and
was co-cultured with feeder cells. The iPSCs were tested positive for alkaline phosphatase activ-
ity and the stem cell specific protein Nanog, giving evidence for pluripotent stem cell proper-
ties. We developed neuronal cells from iPSCs as described in the Methods section to compare
the effect of wortmannin on differentiated and undifferentiated cells. After five weeks co-cul-
ture with feeder cells, iPSC clones we manually picked and subcultured feeder-free in mTeSR1
medium. Spontaneously differentiated cells were removed manually under a microscope. The
thawn iPSCs exhibited hESC-like morphology (Fig 1). Two additional Alzheimer-free iPSC
lines used in this study were subcultivated in E8 medium which was replaced by mTeSR1 one
day before treatment. Both BIHi004-A and BIHi001-A-iPSCs were positive for pluripotency
gene expression of OCT3/4, Sox-2, Nanog detected by RT-qPCR analysis (S1A Fig) and
showed a high alkaline phosphatase ezyme activity (S1B Fig), indicating their pluripotency.
Furthermore these cells could differentiate into neurons as described [39,40].
High basal cell death in iPSCs is caspase-dependent
The AD-iPSCs were cultured on 24 well plates coated with matrigel. Despite daily change of
medium and quickly growing cultures, a significant number of cells died and detached, swim-
ming in the medium both in coculture with feeder cells and under feeder-free conditions. In an
own previous work [43], we found high basal apoptosis in all young and old iPSCs or even
embryonic stem cell lines. Therefore we studied whether this abnormal cell death was caspase-
dependent. AD-iPSCs were treated with 10 μM pan-caspase inhibitor (QVD-oph) and at the
next day significantly fewer dead iPSCs with QVD-oph compared to untreated iPSCs were
observed under light microscope (Fig 2A). Significant reduction of basal apoptosis was proven
using FACS analysis (Fig 2B) and the cell death detection ELISA kit (Fig 2C). Cultivation with
QVD-oph up to two weeks has barely shown morphological changes which could have marked
differentiation. There were only marginal amounts of apoptotic cells with QVD-oph. In con-
trast, untreated AD-iPSCs exhibited many dead cells, as observed under the microscope. Fur-
thermore using an alternative method to quantify apoptosis, BIHi004-A-iPSCs as well as
BIHi001-A-iPSCs showed a significant increase of apoptosis induced by wortmannin, too.
QVD-oph caused a decrease of wortmannin-induced apoptotic cells and also basal apoptotic
cells compared to iPSCs without QVD-oph treatment (Fig 3A). Microscopic pictures of cells
treated with QVD-oph and without are shown in Fig 3B (basal apoptosis).
Morphological changes of iPSC colonies by wortmannin
As shown in Fig 4, striking morphological changes were observed in AD-iPSC colonies com-
pared to original fibroblasts and iPSC-derived neurons. Phase contrast micrographs showed
ragged cell edges after a short time of wortmannin treatment already at a lower concentration
of the inhibitor versus non-treated cells with sharp edges. After a more prolonged incubation
with wortmannin all iPSC colonies were detached. The detached cells swimming in medium
exposed air balloon-like structures after 24 h (Fig 4B). In contrast, neither fibroblasts nor iPSC-
derived neurons showed a visible morphological change like that, even after cell death (Fig 4A
and 4C). Also after 48 h of wortmannin treatment no apoptosis could be observed in control
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fibroblasts and neurons (Fig 4A and 4C). Comparable results were obtained with BIHi004-A
and BIHi001-A iPSCs (S2 Fig).
Wortmannin-induced activation of the mitochondrial apoptotic pathway
and formation of reactive oxygen species (ROS)
Treatment of AD-iPSCs with wortmannin already resulted at early time points (1 h) and at all
concentrations tested (1–4 μM) in a decrease of the mitochondrial membrane potential, a com-
mon early feature of apoptosis, which further decreased with time (Fig 5A and 5B). This effect
could be reproduced using AD-free clones BIHi004-A and BIHi001-A and different concentra-
tions of 0.5–10 μM up to 24 h (S3 Fig). Collapse of mitochondrial membrane potential was
Fig 1. Cultivation and characterization of AD-iPSC colonies for pluripotency. (a) AD-iPSCs one week after thawing on feeder cells. (b) AD-iPSCs two
weeks in culture in high magnification. (c) Typical AD-iPSCmorphology appears 4 weeks after thawing. (d-e) After two years freezing in liquid nitrogen the
AD-iPSCs were positive for pluripotency associated alkaline phosphatase (AP) staining both on feeder cells and in a feeder-free system. (f) The AD-iPSCs
were positive for embryonic stem cell markers such as NANOG. (g) Spontaneous neuronal differentiation of AD-iPSCs in vitro. (h-i) Typical AD-iPSCs
morphology in low and high magnification.
doi:10.1371/journal.pone.0154770.g001
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Fig 2. High basal spontaneous apoptosis in AD-iPSCs is caspase dependent. (A) Pictures were taken
24 h after daily changing medium. (a-b) AD-iPSCs as a control with a lot of dead cells in the supernatant after
24 h in two different magnifications in contrast to iPSCs pretreated with 10 μm caspase inhibitor (c-d). (B)
Employing FACS analysis the apoptosis (percentage of sub-G1 cells) was determined by cell cycle analysis
in AD-iPSCs pretreated with 10 μm caspase inhibitor (QVD-oph) for 2 h and 24 h. After pretreatment of AD-
iPSCs with QVD-oph basal apoptotic cells decreased significantly compared to iPSCs without QVD-oph. (C)
In support to our FACS analysis, apoptosis was quantified by determination of DNA fragmentation using
ELISA cell death detection kit.
doi:10.1371/journal.pone.0154770.g002
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dose- and time-dependent, while treatment for the longest time at highest concentration of wort-
mannin was most efficient. In the two AD-free iPS cell lines we could measure a decrease or no
change of ROS production with different concentrations of wortmannin at various time points
(S4A and S4B Fig). However, we could measure increasing ROS levels by wortmannin in AD-
iPSCs (Fig 5C and 5D), but surprisingly α-tocopherol (Vitamin E) as ROS scavenger did not
Fig 3. Wortmannin induced apoptosis in iPSCs is caspase dependent. (A) In support of our FACS analysis, apoptosis was
quantified by determination of DNA fragmentation using ELISA cell death detection kit. The both iPSCs BIHi004-A and BIHi001-A were
pretreated with QVD-oph or without QVD-oph and subsequently treated for additional 24h with 4μMwortmannin. Insets show picture of
the ELISA with respect to color intensity. The color intensity is proportional to the level of apoptotic cells. (B) Pictures were taken 24 h
after daily changing medium. (a,c) iPSCs as a control with a lot of dead cells in the supernatant after 24 h in two iPSCs in contrast to
iPSCs pretreated with 10 μM caspase inhibitor (b,d).
doi:10.1371/journal.pone.0154770.g003
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prevent wortmannin-induced apoptosis (S5 Fig). This could mean that ROS formation is just an
accompanying effect, but not the responsible trigger of wortmannin-induced mechanism.
Severe apoptosis induction by wortmannin in iPSCs, but not in neurons
and fibroblasts
Apoptotic cells of AD-iPSCs were clearly identified by cell cycle analysis as cells with frag-
mented DNA (sub-G1 cells, Fig 6A and 6C–6F, insets). Treatment with 4 μM of the PI3K
inhibitor wortmannin for 24 h resulted in about 60% apoptosis in AD-iPSCs, whereas the
B-RAF inhibitor L-779,450, the death ligand TRAIL, the IKK inhibitor BMS-345541 and the
Aurora kinase A inhibitor MLN-8237 had, if any, marginal effects (Fig 6A and 6B). In original
fibroblasts only BMS treatment resulted in a slight increase in apoptosis up to 12% (Fig 6C).
Neuronal cells showed a concentration-dependent response to wortmannin after 24 h of treat-
ment (Fig 6D). Induction of apoptosis by wortmannin in AD-iPSCs seemed to be an early
event with 60% apoptosis after only 1 h treatment (Fig 6E). Treatment with the pan-caspase
inhibitor QVD-oph reduced the basal apoptosis from 16% of untreated controls to 6% (Fig
6F). QVD-oph was also able to reduce wortmannin-induced apoptosis from 86% to 30%, lead-
ing to the presumption of a caspase-dependent apoptosis induction in iPSCs (Fig 6F). Simulta-
neously, treatment with QVD-oph resulted in an increased amount of cells at the G2 phase of
Fig 4. Strong apoptotic effect of wortmannin in iPSCs but not in parental fibroblasts and iPSC-derived neurons. Pictures of
fibroblasts, fibroblast derived iPSC lines and iPSC-derived neurons were taken after treatment with 4 μMwortmannin at different time
points (1 h, 2 h, 4 h, 6 h, 24 h) of fibroblasts, fibroblast deriveded iPSCs and iPSC-derived neurons. In contrast to both fibroblasts (NFH-
46) (A) and iPSC-derived neurons (C), iPSCs (B) showed clear sensitivity to wortmannin induced apoptosis, resulting in a massive cell
death with increasing time. The magnifications of all images are 40x.
doi:10.1371/journal.pone.0154770.g004
PI3K/AKT Is Essential for Survival of iPSCs
PLOSONE | DOI:10.1371/journal.pone.0154770 May 3, 2016 11 / 27
growth (Fig 6G). Both AD-free iPSC lines were sensitive to apoptose induction by wortmannin
as well as MK-2206 resulting in massive apoptosis in contrast to the other inhibitors used in
this study. Surprisingly both clones were also a little sensitive to AKA-I inhibitor (Fig 7A–7F).
The parental cells as well as iPS derived neurons were responsive to none of the inhibitors (Fig
7G–7I). Interestingly the use of pancaspase inhibitor QVD-oph in both AD-free iPSC lines
showed a significant inhibition of basal apoptosis decreasing from 18% to 5% as well as wort-
mannin induced apoptosis (75% to 15%) (Fig 8A and 8B). But as also observed for AD-iPSCs,
the detachment of the cells could not be prevented. In order to investigate the function of p53
in wortmannin induced apoptosis, we pretreated the cells with 4 μM, 10μM and 50μM PFT-
alpha followed by 1μMwortmannin. In none of the iPSC lines used PFT-alpha was able to
block the apoptotic effect of wortmannin. (Fig 8C–8E).
Hoechst-33258 staining in iPSCs
The prominent hallmarks of apoptosis are chromatin condensation and DNA fragmentation,
which is a result of indirect activation of caspase-3. We visualised apoptosis, as a second proof,
Fig 5. Decrease of membrane potential and increase of ROS production upon wortmannin treatment in AD-iPSCs. (A) Decreased
membrane potential of mitochondria was determined by flow cytometry after TMRM+ staining in AD-iPSCs. Cells were treated with
different concentrations of wortmannin (1 μM, 2 μM, 4 μM) for different times (1 h, 2 h, 24 h). Treated cells (open graphs) were compared
to untreated controls (gray). (B) The quantitative data represent mean values of triplicate experiments +/-SD. (C) The production of ROS
was determined after H2DCFDA staining in AD-iPSCs treated with two different concentrations of wortmannin (2–4 μM) or 4 μM of MK-
2206 at two different time points (2h, 6h), by flow cytometry. Treated cells (open graphs) were compared to untreated controls (gray). (D)
Quantitative data represent the median values of treated cells compared to control cells. ROS production was depicted as fold-increase,
the control was set to 1. Two independent experiments with triplicates revealed comparable results
doi:10.1371/journal.pone.0154770.g005
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Fig 6. Wortmannin significantly induced apoptosis in AD-iPSCs. (A) Apoptosis (percentage of sub-G1 cells) was determined by
cell cycle analysis in iPSCs treated for 24 h with 10 μMQVD-oph, 10ng/ml TRAIL, 4 μMwortmannin (Wort.), 4 μM L-779,450, 4 μM
BMS, and 50 nMMLN-8237 (AKA-I). Insets: Histogram examples of cells treated with wortmannin or BMS as compared to controls
(Con.). Sub-G1 cell populations are indicated (sG1). (B) Whole cell cycle analysis after treatment with small molecules mentioned in A
with respect to the amount of different phases (sub-G1, G1, S, G2/M) in percent. (C) Apoptosis (percentage of sub-G1 cells) was
determined by cell cycle analysis in orginal fibroblasts treated for 24 h with 10 μMQVD-oph, 10ng/ml TRAIL, 4 μMwortmannin, 4 μM
L-779,450, 4 μMBMS, and 10 μMAKA-I. Insets: Histogram examples of cells treated with wortmannin or BMS compared to controls.
Sub-G1 cell populations are indicated (sG1). (D) Apoptosis (percentage of sub-G1 cells) was determined by cell cycle analysis in
iPSC-derived neurons treated with increasing concentrations (0.5, 1, 2, 4 μM) of wortmannin for 24 h. Insets: Histogram examples of
cells treated with two different concentrations of wortmannin (0.5/2 μM) compared to controls. (E) Measurement of apoptosis after
treatment with 4 μMwortmannin for 1 h compared to DMSO. (F) Apoptosis (percentage of sub-G1 cells) by 10 μMQVD-oph, 4 μM
wortmannin or the combination of both in iPSCs after 24 h. (G) Percentages of different cell phases of iPSCs treated with 10 μMQVD-
oph, 4 μMwortmannin or the combination of both for 24 h. Means and SDs are shown of three independent experiments in triplicates.
Statistical significance (*; p < 0.05) is indicated for comparison of control cells and wortmannin-treated cells.
doi:10.1371/journal.pone.0154770.g006
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Fig 7. Wortmannin significantly induced apoptosis in BIHi001-A and BIHi004-A iPSC lines. (A,E)
Apoptosis (percentage of sub-G1 cells) was determined by cell cycle analysis in iPSCs treated for 24 h with
10ng/ml TRAIL, 4 μM L-779,450, 4 μMBMS, 50 nMMLN-8237 (AKA-I), 4 μMMK-2206, 4 μMwortmannin
(Wort.). (B,F) Whole cell cycle analysis after treatment with small molecules mentioned in A with respect to
the amount of different phases (sub-G1, G1, S, G2/M) in percent. (C,D) Histogram examples of cells treated
with BMS, AKA-I or wortmannin as compared to controls (DMSO). Sub-G1 cell populations are indicated
(sG1). (G) Apoptosis (percentage of sub-G1 cells) was determined by cell cycle analysis in orginal fibroblasts
(HFF and NHDF) treated for 24 h with 10ng/ml TRAIL, 4 μM L-779,450, 4 μMBMS, 50 nMMLN-8237 (AKA-I),
4 μMMK-2206, 4 μMwortmannin (Wort.). Insets: Histogram examples of cells treated with AKA-I or
PI3K/AKT Is Essential for Survival of iPSCs
PLOSONE | DOI:10.1371/journal.pone.0154770 May 3, 2016 14 / 27
by Hoechst-33258 staining in the iPSCs 1 h after treatment mit 4 μmwortmannin. As shown
in Fig 9 (AD-iPSCs) and S6 Fig. (BIHi004-A and BIHi001-A) wortmannin-treated iPSCs
exhibited a brighter blue-whitish fluorescent appearance compared to untreated iPSCs. Fur-
thermore, it was always striking that wortmannin treated iPSC clones clearly showed intense
blue color at the edges. Interestingly, the mitotic cells in controls, but also in treated cells, were
visible with deep intense blue staining, which suggested that the iPSCs were highly proliferative
cells.
Protein analysis of spontaneous apoptosis in AD-iPSCs
We reported in our previous work, that all young and old iPSCs and ESC lines used showed
high apoptosis at the basal level. We could also show all iPSCs analyzed possessed a similar
hypersensitivity to cytostatic agent-induced apoptosis in comparison to corresponding paren-
tal fibroblasts. This suggested that conversion of fibroblasts into iPSCs may reprogram the sig-
naling apoptosis pathway on an epigenetic level.
We have observed the same events in this study. Therefore we collected the dead cells (DC)
and analysed apoptosis-related proteins as shown in Fig 10A and 10B in the last lane on the
right side of the blots: The proteins P-AKT, AKT, P-BAD and p53 were not detectable (Fig
10A, lane DC). In contrast, prominent proapoptotic proteins such as BAX and BAK were
strongly expressed and antiapoptotic proteins such as Bcl-XL and Bcl-2 compared to proapop-
totic proteins were only moderately expressed (Fig 10B, lane DC). In addition to specific bands
of BAX and BAK we have detected additional bands, which are approximately 15 kDa and 17
kDa, repectively. Interestingly, we could detect a large amount of a distinct cleavage product of
caspase-3, which indicates caspase-3 activation (Fig 10A, lane DC). Autophagy is a type of pro-
grammed cell death and it takes place with the help of autophagic marker proteins, like the
cytoplasmic protein LC3-I and the membrane-binding LC3-II. Fig 10A, lane DC shows a shift
of the LC3-II band, suggesting phosphorylation could have occurred here, which would have
led to protein inactivation [44].
Protein analysis of wortmannin induced apoptosis in AD-iPSCs
We analysed the expression of relevant proteins that are involved in classical apoptosis and
PI3kinase pathways in AD-iPSCs in response to 4 μMwortmannin. After treatment times of
20, 40, 60 and 180 min., cells were lysed directly and the protein expression levels of p-AKT,
AKT, p-BAD, p53, cleaved caspase-3, LC3I, LC3II, BAX, BAK, BCL-2, BCL-XL and PUMA
were investigated (Fig 10A and 10B). Expression of AKT, a downstream target protein in the
PI3K pathway, remained unchanged, whereas the phosphorylation of AKT as survival signal
disappeared after 20 min. Pro-apoptotic activity of BAD is regulated through its phosphoryla-
tion via phosphorylated AKT. In our analysis we detected a decrease of phosphorylated BAD
indicating pro-apototic activation. Furthermore, we did not observe any changes in LC3I and
LC3II as autophagy markers, but a time-dependent decrease in expression of p53. According
to these results and to the lacking effect of PFT-alpha (Fig 8C–8E), it seems likely that p53 pro-
tein is not involved in wortmannin induced apoptosis in our study. However, wortmannin-
wortmannin compared to controls (DMSO). Sub-G1 cell populations are indicated (sG1). (H,I) Apoptosis
(percentage of sub-G1 cells) was determined by cell cycle analysis in two iPSC-derived neurons treated for
24 h with 10ng/ml TRAIL, 4 μM L-779,450, 4 μMBMS, 50 nMMLN-8237 (AKA-I), 4 μMMK-2206, 4 μM
wortmannin (Wort.). Insets: Histogram examples of cells treated with, BMS, AKA-I or wortmannin compared
to controls (DMSO). Means and SDs are shown of three independent experiments in triplicates. Statistical
significance (*; p < 0.05) is indicated for comparison of control cells and wortmannin-treated cells.
doi:10.1371/journal.pone.0154770.g007
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Fig 8. Wortmannin induced apoptosis can be blocked by pancaspase inhibitor but not by p53 inhibitor.
(A,B) Apoptosis (percentage of sub-G1 cells) was determined by cell cycle analysis in both BHIi001-A and
BHIi004-A iPSC lines treated with 10 μM pancaspasen Inhibitor (QVD-oph, 2h pretreatment) and subsequently
with 4 μMwortmannin (Wort.) for additional 24h. Insets: Histogram examples of cells treated with wortmannin,
QVD or QVD combined with Wortmannin as compared to controls (Con.). Sub-G1 cell populations are indicated
(sG1). (C-E) Apoptosis (percentage of sub-G1 cells) was determined by cell cycle analysis in AD-iPSCs,
BIHi001-A and BIHi004-A, all three iPSC lines pretreated with 4μM, 10μM and 50μM p53 inhibitor (PFT-alpha)
and subsequently with 1μMwortmannin (Wort.) for additional 24h. Insets: Histogram examples of cells treated
with PFT-alpha alone or PFT-alpha combined with wortmannin compared to controls. Sub-G1 cell populations
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induced apoptosis was caspase-dependent, since we found a significant increase in the cleaved
form of caspase-3 (Fig 10A).
The role of BCL-2 proteins in wortmannin-induced apoptosis in AD-iPSCs
The ratio of anti-apoptotic to pro-apoptotic Bcl-2 family members determines the cell fate
[17]. Protein analysis showed equal amounts of BAX and BAK as pro-apoptotic and Bcl-2 and
Bcl-XL as anti-apoptotic proteins. But the ratio of pro-apoptotic to anti-apoptotic proteins was
already high in the control AD-iPSCs. PUMA, another pro-apoptotic protein, regulated via
p53, remained unchanged until 60 min. and was thereafter not detectable (Fig 10B).
are indicated (sG1). Means and SDs are shown of three independent experiments in triplicates. Statistical
significance (*; p < 0.05) is indicated for comparison of control cells and wortmannin-treated cells.
doi:10.1371/journal.pone.0154770.g008
Fig 9. Wortmannin induced apoptosis in iPSCs causes nuclear condensation and fragmentation detected by Hoechst-33258
staining. (A) Phase contrast of untreated AD-iPSCs with sharp edges of round colonies (a) untreated AD-iPSC clones showmitotic
cells, which can be seen by as intense blue (b-c). Phase contrast of wortmannin treated AD-iPSCs with frayed edges 1 h after treatment
with 4μMwortmannin (d). A high proportion of cells showed clear indication of apoptosis by nuclear condensation and fragmentation,
particularly pronounced at the edge of the colonies of AD-iPSCs (d-f) (examples indicated by arrows). B: Magnified images of untreated
AD-iPSCs marked as mitotic cells (a), diffuse blue nucleus (b), sharp edge of untreated colony (c), magnified images of apoptotic cells
with DNA condensation, DNA fragmentation (d-g). Changes in the morphology of the colonies one hour after treatment with wortmannin,
and after 24 h complete detachment of the AD-iPSCs have been observed (h-i).
doi:10.1371/journal.pone.0154770.g009
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Altered basal protein expression after differentiation of AD-iPSCs into
neurons
Interestingly, differential protein expression between iPSCs and iPSC-derived neurons with
respect to AKT, p-AKT and LC3 proteins could be detected. As shown in Fig 11A the basal
expression of AKT in AD-iPSC-derived neurons was tenfold higher compared to AD-iPSCs.
Furthermore, higher levels of phosphorylated AKT were detected in neurons. On the other
hand, p-AKT was significantly downregulated (8-fold) in neurons after 3 and 6 h of wortman-
nin treatment, and 24 h later the cells upregulated p-AKT again and were alive. The basal
expression of LC3 was 5-fold higher than in AD-iPSCs. Regarding caspase-3 activity, we
detected the cleaved caspase-3 only in AD-iPSCs after 3 h of wortmannin treatment, but not in
AD-iPSC-derived neurons or orginal fibroblasts, as shown in Fig 11B.
Discussion
A sensational development in the field of regenerative medicine and stem cell research was the
achievement of cells with many properties in common with hESCs without the use of embryos
[1,45]. In order to study disease mechanisms in a dish, the iPSC technology gives us valuable
Fig 10. Western blot analysis of key proteins of apoptosis in wortmannin treated AD-iPSCs. Protein lysates were analyzed in
AD-iPSCs after treatment with 4 μMwortmannin for different times. On the last lane of the blot at the right we subjected protein lysate of
dead cells (DC) raised after 24 h in the supernatant to follow the basal apoptosis. Fourty μg of protein each were separated by
SDS-PAGE (12%). Western blot analysis was used to monitor the expression of phosphorylated AKT (p-AKT, at serine 473) and total
AKT, phosphorylated BAD and total BAD and p53. The anti-human Caspase-3 antibody used recognizes only the cleaved active form
of caspase-3. The anti-human LC3A antibody recognizes both isomers, LC3I and LC3II. Furthermore we used anti-human BAX, BAK,
BCL-2, BCL-XL and PUMA antibodies, against members of the Bcl-2 family. Beta-actin and Coomassie blue staining were used to
confirm similar protein loading across samples.
doi:10.1371/journal.pone.0154770.g010
PI3K/AKT Is Essential for Survival of iPSCs
PLOSONE | DOI:10.1371/journal.pone.0154770 May 3, 2016 18 / 27
insight into poorly accessible disease-affected materials such as brain cells and has several
advantages over the current possibilities of investigation. Meanwhile several researchers world-
wide have succeeded to develop patient-specific iPSCs from various diseased somatic cells and
to differentiate them into desired cell types that are defect or lost in certain diseases [46]. Nev-
ertheless there are several obstacles that must be resolved before routine use. The system of
gene delivery will have to be improved in order to avoid genetic destabilization, the method
Fig 11. Comparative analysis of proteins between AD-iPSCs and AD-iPSC-derived neurons after wortmannin treatment. Protein
lysates of AD-iPSCs and iPSC-derived neurons (INC) were analyzed after treatment with 4μMwortmannin for different times. Fourty μg
of protein each were separated by SDS-PAGE (12%). (A) Western blot analysis was used to monitor the expression of total and
phosphorylated Akt (p-Akt, at serine 473). The anti-human LC3A recognizes both isoforms LC3I and LC3II and could also show
phosphorylated LC3II. (B) iPSCs compared to iPSC-derived neurons and original fibroblasts. The anti-human Caspase-3 used
recognizes only the cleaved active form of caspase-3. Beta-tubulin and Coomassie blue staining were used to confirm similar protein
loading across samples.
doi:10.1371/journal.pone.0154770.g011
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should become faster and more efficient, and differentiated cells will have to be free of “con-
taminating” iPSCs after differentiation in order to avoid tumor formation in case of cell trans-
plantation. Since they may recapitulate a similar genetic background, they may only be used
for cell transplantation after correction of the causes of the disease. Unlike human ESCs,
human iPSCs acquire most chromosomal aberrations during induction of cellular reprogram-
ming or long-term cultivation, which may cause tumorigenity and apoptosis resistance [47,48].
Chromosomal aberration is one of the important reasons for tumorigenicity in cancer cells. In
a previous study we have reported that the generated iPSCs acquired chromosomal aberrations
[43]. This is in accordance to other iPSC studies [49]. Surprisingly, despite their continuous
growth under optimal culture conditions or/and chromosomal aberrations, all developed
iPSCs and ESCs displayed high spontaneous apoptosis. They also were highly sensitive to apo-
ptosis inducers such as cytostatic actinomycine C [43] and in another report the iPSCs were
highly sensitive for apoptosis after irradiation treatment, [50]. Nevertheless the same iPSCs
used in our study or in the other study formed teratoma in mice [5,43,51,52]. Therefore, the
tumour-like iPSCs would be very interesting as a model to study tumorigenesis, since they
behave as cancer cells due to unlimited proliferation, formation of teratoma in mice and genetic
aberrations.
On the other hand, two studies dealed with the mechanism of cell death in iPSCs and ESCs
using small molecules. These were directed to pathways involved in cell survival, apoptosis and
adhesion molecule signaling and tried to elucidate the underlying mechanisms and to achieve
an improvement in keeping "well-doing" iPSCs during passages and culture periods with
reduced basal apoptosis [53,54]. Addition of Rock inhibitor to extracellular matrix was shown
to significantly reduce spontaneous basal cell death and to increase plating efficiency of hESC
and hiPSCs during a culture period. The proposed mechanisms for this positive effect were the
induced expression of integrins αv, α6, ß1, and ß5 detected by RT-qPCR analysis [53]. Further-
more and regarding apoptosis, the use of Maxadilan activated the pituitary adenylate cyclase-
activating polypeptide (PACAP) type I receptor (PAC1) in iPSCs, prevented apoptosis induced
by ultraviolet C (UVC) and interestingly had no effect on pluripotent properties and karyotype
state [54]. The anti-apoptotic effect was suggested to be due to downregulation of caspase-3
and caspase-8. We have also observed a conspicuous spontaneous basal cell death under both
conditions, on feeder cells and in feeder-free medium in our study. Therefore, we collected the
dead cells from medium and analyzed their proteins in comparison to adherent AD-iPSCs in
terms of prominent apoptosis-associated proteins. The Western blot analysis of dead AD-
iPSCs revealed a significantly high expression of the pro-apoptotic proteins BAX and BAK
compared to the anti-apoptotic proteins BCL-2 and BCL-XL, which control the release of pro-
apoptotic proteins, such as cytochrome C, from mitochondria into the cytosol [55]. The rela-
tive concentration of pro- and anti-apoptotic proteins may act as a rheostat for cell suicide pro-
grams and lead to a sensitization for basal apoptosis [17]. We have also detected a shift of the
lower band of marker of autophagy LC3II protein compared to adherent AD-iPSCs, which is
probably due to the phosphorylation and subsequent inactivation of this protein [44]. Further-
more, we detected a significant increase of cleaved caspase-3 compared with adherent AD-
iPSCs as control. Consistent with our findings of enhanced caspase activity, the use of the pan-
caspase inhibitor QVD-oph clearly reduced the number of dead AD-iPSCs under constant
morphology and growth up to two weeks. We conclude that caspase-3 is an essential effector
caspase involved in the spontaneous death of iPSCs under feeder and feeder free based matri-
gel-coated culture conditions. However, we cannot exclude that other caspases of this family
play a role in this context. Therefore it would be interesting to apply selective caspase inhibitors
for caspase-3, -8 and -9, in order to check their role regading spontaneous death in this cell
model.
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The other important finding in this study is that wortmannin, as an inhibitor of the PI3K
signaling pathway, dramatically induced iPSC apoptosis in a caspase-dependent manner as
shown not only for AD-iPSCs, but also for two AD-free iPSC lines. The PI3K signaling path-
way and especially its downstream protein AKT are of great importance in mouse ESCs and
early embryos and are considered crucial for unlimited proliferation and survival as well as for
inhibition of the apoptotic processes [21]. AKT can phosphorylate and dephosphorylate vari-
ous target proteins to ensure the healthy normal growth and viability of the cells. Overexpres-
sion of AKT in this pathway due to mutations can contribute to cell tumorigenesis. It can cause
apoptosis resistance and aggressive growth behavior, e.g. by dysregulation of Bad and p53
which are target genes of AKT [56]. It has been recently reported that melanoma cells are resis-
tant to wortmannin, but on the other hand they become sensitized to apoptosis in combination
with TRAIL [26]. This is due to formation of ROS which leads to BAX activation by its phos-
phorylation and downregulation of phosphorylated AKT [26]. We also detected an increase of
ROS and markedly decreased P-AKT in our AD-iPSCs after wortmannin treatment, although
ROS increase could not be seen in the other two iPSC lines used. But ROS levels can be
extremely time-dependent so that an increase in the BIHi-clones cannot be excluded. High
expression of AKT or a deregulated PI3K-AKT signaling pathway was responsible for the resis-
tance of MCF-7 to various chemotherapeutics such as etoposide, doxorubicin and camptothe-
cin. However, application of wortmannin in breast cancer cells MCF-7 induced apoptosis with
pronounced morphological and biochemical apoptotic properties, suggesting AKT as a poten-
tial target gene in breast cancer cell therapy [57]. In iPSCs, however, the role of the PI3K/AKT
pathway has been, to our knowledge, not yet defined.
For this work we have reviewed a number of small biological molecules in terms of their
effectiveness to cell viability and apoptosis in iPSCs, but wortmannin and MK-2206 were the
only to induce cell death in iPSCs, and that with a dramatic effect. Surprisingly, orginal fibro-
blasts as well as iPSC-derived neurons showed no response to wortmannin regarding apoptosis
induction, although AKT protein levels were significantly high in contrast to AD-iPSCs. But
high expression of AKT could perhaps especially be the reason for the lack of response, which
was also described for MCF-7 and other tumor cells resistant to apoptosis and chemotherapeu-
tics as mentioned above [57]. Different AKT protein levels from original fibroblasts, AD-iPSCs
and AD-iPSC-derived neurons with the same genetic origin could be due to epigenetic changes
by reprogramming as well as by differentiation. However, there are several recent studies show-
ing that iPSCs retain the genetic and epigenetic background of the cells of origin [58–60]. On
the other hand, it is controversially reported that iPSCs and ESCs are not close to each other in
terms of molecular nature, while others indicate great similarities in this respect [59,61,62]. In
contrast to iPSCs, the original fibroblasts used here showed no apoptotic effect for wortmannin
treatment even after 48 h, but instead NHF-46 were more sensitive to the IKK inhibitor BMS-
345541 affecting the NF-kappaB signaling pathway so that AD-iPSCs seemed to have acquired
resistance to the latter inhibitor. Since NF-kappaB signaling has been described as very impor-
tant for maintaining the undifferentiated state of iPSCs [63], high activity of the pathway as
assumed above for the PI3K/AKT pathway could be the cause of the lack of reaction. For con-
firmation, we also treated another series of skin fibroblasts obtained from a young healthy
woman under identical conditions, but apoptosis induction was not seen upon wortmannin
treatment (S7 Fig).
In the iPSCs we could significantly inhibit wortmannin-induced apoptosis (with involve-
ment of caspase-3) by 50–80% using the pan-caspase inhibitor QVD-oph. On the other hand,
the caspase inhibitor could not prevent detachment of iPSCs. It is, therefore, assumed that
wortmannin possibly exerts its effect via multiple pathways. We subsequently focused on the
role of p53 activation in mediating apoptotic response by wortmannin using PFT-alpha in all
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iPSCs, but we could not detect any inhibiton of apoptosis. Wortmannin did not change the
ratio of the pro- and anti-apoptotic Bcl-2 family members BAX, BAK to BCL-2, BCL-XL in
AD-iPSCs, which remained at its high level. Several reports demonstrated that the ratio of pro-
apoptotic to anti-apoptotic Bcl-2 proteins determines cell fate in cancer cells, whether cells can
stay alive or die after treatment with apoptotic stimuli [17,64]. Based on our findings and other
studies, we have hypothesized that the iPSCs should be sensitive to TRAIL treatment, but we
did not detect apoptosis on a morphological or biochemical level. Probably the TRAIL-induced
apoptosis signaling pathway is not sufficiently developed in our iPSCs and they could behave
like tumor cells with resistance to apoptosis. It would be interesting to check further anti-apo-
ptotic proteins such as inhibitors of apoptosis (IAPs) and others. Further protein analysis
revealed that after short incubation times with wortmannin phosphorylated AKT began to
decrease with increasing time in AD-iPSCs, underlined by consistent AKT expression. Phos-
phorylation of AKT provides survival and blocking of apoptosis. Interestingly, AD-iPSC-
derived neurons behaved similarly (on a higher initial level), but after 24 hours P-AKT
increased again and we observed no relevant apoptosis induction after treatment with
wortmannin.
In conclusion, our results indicate the importance of the PI3K-AKT signaling pathway and
of caspase-3 activity in our AD-iPSCs derived from skin fibroblasts, concerning survival and
apoptosis. As far as we know, we were the first to efficiently reduce basal cell death using QVD-
oph, to avoid spontaneous differentiation over two weeks and to highlight the role of the PI3K
pathway for (AD-derived) iPSCs. The specificity of action could also be shown with low levels
of wortmannin. Different responses and expression levels of the three cell types, the original
cells, AD-iPSCs and AD-iPSC-derived neuronal cells suggest changes in the epigenetic back-
ground. Regarding iPSC-based therapies with the risk of tumour development, apoptotic elimi-
nation of remaining undifferentiated iPSCs using wortmannin could be a suitable solution for
tumour prevention. Therefore, it would be interesting to investigate the apoptotic effect of
wortmannin in vivo after injection of iPSCs in mice. Interestingly, the Alzheimer and Alzhei-
mer-free iPSC lines showed no differences in apoptotic behaviour mediated by wortmannin
treatment. Since the iPSCs research is growing rapidly and gets enormous importance for the
elucidation of the molecular pathogenesis and on the other side valuable insight for stem cell-
based therapy, we hope that these findings are helpful for understanding the mechanisms of
survival and apoptosis.
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S1 Fig. Characterization of iPSC colonies for pluripotency and neuronal differentiation. A)
RT-qPCR analysis of pluripotency gene expression of OCT3/4, Sox-2, Nanog in both iPSC
lines, BHIi004-A and BHIi001-A. WAe001-A (H1) embryonic stell cells and HFF were used
here as positive and negative controls for pluripotency genes, respectively. B) (a-c): They were
positive for pluripotency-associated alkaline phosphatase (AP) staining in a feeder-free system.
(d-f) Typical iPSC morphology. Neuronal differentiation of both iPSCs after infection of lenti-
viral vector containing Ngn2 (h, light picture) and Ngn2 with GFP as reporter gene (g, green
fluorescent protein).
(PDF)
S2 Fig. Strong apoptotic effect of wortmannin in both BIHi001-A and BIHi004-A iPSC
lines but not in their parental fibroblasts and iPSC-derived neurons. Pictures were taken
after treatment with 4 μMwortmannin at different times (1 h, 2 h, 6 h, 24 h) of two fibroblast
cell lines, corresponding fibroblast derived iPSCs and iPSC-derived neurons. In contrast to
both fibroblast cell lines (HFF and NHDF) (A) and iPSC-derived neurons (C), iPSCs
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BHIi001-A and BHIi004-A (B) showed clear sensitivity to wortmannin induced apoptosis,
resulting in a massive cell death with increasing time. The magnifications of all images are 40x.
(PDF)
S3 Fig. Decrease of membrane potential upon wortmannin treatment in BIHi001-A and
BIHi004-A iPSC lines. (A,C) Decreased membrane potential of mitochondria was determined
by flow cytometry after TMRM+ staining in iPSCs BIHi001-A and BIHi004-A. Cells were
treated with different concentrations of wortmannin (0.5 μM, 2 μM, 4 μM, 10μM) for different
times (2 h, 3 h, 7h, 24 h). Treated cells (red) were compared to untreated controls (gray). (B,D)
The quantitative data represent mean values of triplicate experiments +/-SD.
(PDF)
S4 Fig. No changes in ROS production upon wortmannin treatment in both iPSCs
BIHi001-A and BIHi004-A. (A,B) The production of ROS was determined after H2DCFDA
staining in AD-iPSCs treated with three different concentrations of wortmannin (0,5–4 μM) or
at three different time points (0.5h, 2h, 4h) by flow cytometry. Treated cells (open graphs) were
compared to untreated controls (pink). Two independent experiments with triplicates of both
iPS cell lines revealed comparable results.
(PDF)
S5 Fig. Wortmannin induced apoptosis was not blocked applying Vitamin E (Vit E) in AD-
iPSCs.Apoptosis (percentage of sub-G1 cells) was determined by cell cycle analysis in AD-iPSCs
pretreated for 2 h with 10 μMalpha-tocopherol (Vit E) and subsequently treated for 24h with 2μM
and 4μMwortmannin. Histogram examples of cells treated with wortmannin alone or in combina-
tion with Vit E as compared to controls (Con.). Sub-G1 cell populations are indicated (sG1).
(PDF)
S6 Fig. Wortmannin induced apoptosis in iPSCs causes nuclear condensation and frag-
mentation detected by Hoechst-33258 staining. (A) Phase contrast of untreated iPSCs
BIHi001-A and BIHi004-A with sharp edges of round colonies (a,b). Untreated iPSC clones
show mitotic cells, which can be seen as intense staining, but most of the cells are diffuse blue
(e,f). Wortmannin treated iPSCs with frayed edges 2 h after treatment with 4μMwortmannin
can be seen in phase contrast (c,d) and as intense blue (g,h). A high proportion of cells showed
clear indication of apoptosis by nuclear condensation and fragmentation, particularly pro-
nounced at the edge of the colonies of iPSCs).
(PDF)
S7 Fig. No apoptotic effect of wortmannin in healthy fibroblasts. (A) Apoptosis (percentage
of sub-G1 cells) was determined by cell cycle analysis in healthy fibroblasts treated for 48h h
with 4 μMwortmannin, compared to controls. Sub-G1 cell populations are indicated (sG1).
(B) Pictures of fibroblasts were taken after 48 h treatment with 4 μMwortmannin. Magnifica-
tion 40x.
(PDF)
S1 Table. List of primer pairs for pluripotency genes used in this study.
(XLSX)
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